Banque Transatlantique’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55M Buy
49,374
+3,053
+7% +$3.12M 1.18% 20
2026
Q1
$43.2M Sell
46,321
-23,379
-34% -$23.7M 1.04% 23
2025
Q4
$75M Sell
69,700
-65,889
-49% -$63M 1.82% 13
2025
Q3
$104M Sell
135,589
-12,126
-8% -$9.02M 2.54% 11
2025
Q2
$116M Buy
147,715
+17,297
+13% +$13.4M 3.19% 10
2025
Q1
$108M Sell
130,418
-7,812
-6% -$6.5M 3.25% 9
2024
Q4
$92.6M Buy
+138,230
New +$114M 2.36% 12

Other funds holding LLY

Banque Transatlantique's LLY Position: Q2 2026 in Review

Banque Transatlantique increased its Eli Lilly (LLY) stake by 6.6% in Q2 2026, buying an estimated $3.12M and bringing the position to 49,374 shares worth $55M. The position accounts for 1.18% of the portfolio, ranked #20.

Banque Transatlantique first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $116M in Q2 2025. 2,373 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Banque Transatlantique held 49,374 shares of Eli Lilly worth $55M as of Q2 2026.
  • Banque Transatlantique bought 3,053 Eli Lilly shares in Q2 2026, an estimated $3.12M.
  • Eli Lilly made up 1.18% of Banque Transatlantique's portfolio in Q2 2026, its #20 holding.
  • Banque Transatlantique first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Eli Lilly position peaked at $116M in Q2 2025.
  • 2,373 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.